TABLE III -.
Authors | Total isolates | Total ESBL-producer | Antimicrobial resistance profiles | |||||||
---|---|---|---|---|---|---|---|---|---|---|
CAZ | CTX | GNT | CIP | SXT | TET | AMC | MDR | |||
AMC = ampicillin-clavulanic acid; CAZ = ceftazidime; CI = confidence interval; CIP = ciprofloxacin; CTX = cefotaxime; GNT = gentamicin; ESBL = extended-spectrum beta-lactamase; MDR = multi-drug resistance; NA = not analyzed; R = resistance; SXT = trimethoprim-sulfamethoxazole; TET = tetracycline; ES = event rate. | ||||||||||
*From overall isolates. | ||||||||||
Desta et al. (2016) | 295 | 151/295 | 137/150 | 146/150 | 105/150 | 94/150 | 136/150 | NA | 134/150 | 150/150 |
Teklu et al. (2019) | 426 | 246/426 | 257/426 | 265/426 | 185/426 | 240/426 | 324/426 | NA | 305/426 | 237/246 or 291/426* |
Moges et al. (2019) | 185 | 127/148 | 143/148 | 129/148 | 116/148 | 52/148 | 138/148 | 127/148 | 117/148 | 127/148 or 148/185* |
Legese et al. (2017) | 33 | 22/28 | NA | 29/33 | 26/33 | NA | 29/33 | 25/33 | 28/33 | NA |
Engda et al. (2018) | 57 | 57/57 | 57/57 | 57/57 | 11/57 | 25/57 | 37/57 | NA | 57/57 | 32/57 |
Gashaw et al. (2018) | 100 | 51/100 | 63/100 | 60/100 | 68/100 | 48/100 | 79/100 | 90/100 | 94/100 | 28/100* |
Mulualem et al. (2012) | 67 | 24/67 | 4/67 | 6/67 | 2/67 | 14/67 | 38/67 | 49/67 | 47/67 | 67/67* |
Zeynudin et al. (2018) | 224 | 71/112 | 63/68 | 66/68 | 60/68 | 41/68 | 62/68 | NA | NA | 67/68* |
Eshetie et al. (2015) | 183 | 5/183 | 90/160 | 40/160 | 94/160 | 4/160 | 103/160 | 79/160 | 81/160 | 160/183* |
Beyene et al. (2011) | 113 | 71/113 | NA | NA | 84 | 1 | 91 | 45 | NA | 78/113* |
Abera et al. (2016) | 274 | 127/274 | NA | NA | NA | 106/274 | 174/274 | NA | NA | NA |
Seid et al. (2005) | 57 | 19/57 | 23/57 | 22/57 | 35/57 | NA | 37/57 | NA | NA | 41/57* |
Abayneh et al. (2018) | 74 | 17/74 | 12/17 | 17/17 | 11/17 | 13/17 | 14/17 | 14/17 | 14/17 | 14/17 |
Siraj et al. (2014) | 112 | 43/112 | 42/43 | 43/43 | 36/43 | 33/43 | 41/43 | 39/43 | 38/43 | 38/43 |
Mulisa et al. (2016) | 68 | 17/68 | NA | NA | 12/17 | 14/17 | 14/17 | 6/17 | NA | 17/17 |
Bitew (2019) | 135 | 66/135 | 45/135 | NA | 32/135 | 47/135 | 86/135 | 92/135 | 100/135 | 110/135* |
Beyene (2019) | 238 | 159/238 | 176/238 | NA | 117/238 | 137/238 | 195/238 | 191/238 | 148/238 | 225/238* |
Overall R, ES [95% CI] | 1273/2487 | 0.72 [0.586, 0.820] | 0.78 [0.615, 0.891] | 0.589 [0.482, 0.688] | 0.438 [0.347, 0.534] | 0.784 [0.726, 0.832] | 0.727 [0.605, 0.823] | 0.790 [0.713, 0.850] | 0.827 [0.726, 0.896] |